Telefon:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@antikoerper-online.de

IDO1 Antikörper

Dieser Maus Monoklonal Antikörper detektiert spezifisch IDO1 in WB, ELISA und IHC. Es zeigt Reaktivität gegenüber Proben von Human.
Produktnummer ABIN1169197
405,15 €
Zzgl. Versandkosten 20,00 € und MwSt
Lieferung nach: Deutschland
Lieferung in 2 bis 5 Werktagen

Kurzübersicht für IDO1 Antikörper (ABIN1169197)

Target

Alle IDO1 Antikörper anzeigen
IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

Reaktivität

  • 111
  • 15
  • 9
  • 1
  • 1
  • 1
Human

Wirt

  • 105
  • 13
  • 2
  • 1
Maus

Klonalität

  • 90
  • 31
  • 1
Monoklonal

Konjugat

  • 64
  • 7
  • 7
  • 4
  • 3
  • 3
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Dieser IDO1 Antikörper ist unkonjugiert

Applikation

  • 82
  • 39
  • 35
  • 29
  • 23
  • 22
  • 17
  • 16
  • 15
  • 9
  • 7
  • 2
  • 2
  • 1
  • 1
  • 1
Western Blotting (WB), ELISA, Immunohistochemistry (IHC)

Klon

ID 177
  • Verwendungszweck

    anti-IDO (human), mAb (ID 177)

    Spezifität

    Recognizes human IDO1. Detects a band of ~45 kDa by Western blot. Other species not tested.

    Kreuzreaktivität (Details)

    Other species not tested.

    Produktmerkmale

    Monoclonal Antibody. Recognizes human IDO. Detects a band of ~45 kDa by Western blot. Other species not tested. Isotype: Mouse IgG1kappa. Clone: ID 177. Applications: ELISA, IHC, WB. Liquid. 0.2μm-filtered solution in PBS, pH 7.4. Contains no preservatives. IDO catalyzes the first and rate-limiting step in the main pathway of human tryptophan catabolism, the kynurenine pathway. Proinflammatory mediators, such as endotoxin and IFN-gamma induce the expression of IDO in several tissues. IDO-dependent suppression of T-cell responses might function as natural immunoregulatory mechanism. Physiological IDO activity has been implicated in T-cell tolerance to tumors, dysfunctional selftolerance in non-obese diabetic (NOD) mice, and as a protective negative regulator in autoimmune disorders.

    Sterilität

    0.2 μm filtered

    Immunogen

    Recombinant human IDO1.

    Isotyp

    IgG1 kappa
  • Applikationshinweise

    Optimal working dilution should be determined by the investigator.

    Beschränkungen

    Nur für Forschungszwecke einsetzbar
  • Format

    Liquid

    Konzentration

    1 mg/mL

    Buffer

    0.2μm-filtered solution in PBS, pH 7.4.

    Konservierungsmittel

    Without preservative

    Handhabung

    After opening, prepare aliquots and store at -20 °C.Avoid freeze/thaw cycles.

    Lagerung

    4 °C,-20 °C

    Informationen zur Lagerung

    +4°C

    -20°C

    Stable for at least 1 year after receipt when stored at -20°C.

    Haltbarkeit

    12 months
  • Target

    IDO1 (Indoleamine 2,3-Dioxygenase 1 (IDO1))

    Andere Bezeichnung

    IDO

    Hintergrund

    Alternate Names/Synonyms: Indoleamine 2,3-dioxygenase 1, IDO, INDO

    Product Description: IDO1 is a heme enzyme that catalyzes the first and rate-limiting step in the main pathway of human tryptophan catabolism, the kynurenine pathway, causing depletion of tryptophan which can lead to halted growth of microbes as well as T cells. IDO1 is an immune checkpoint protein, thought to play a role in a variety of pathophysiological processes such as antimicrobial and antitumor defense, neuropathology, immunoregulation and antioxidant activity. Cancer cells are able to evade the immune system is by hijacking the checkpoint proteins. Increased IDO1 protein levels drive growth arrest and apoptosis of the effector T cells, a group of immune cells that mediate the immune system's ability to destroy pathogens. By reducing the number of effector T cells, IDO1 overexpression prevents the immune system from effectively destroying cancer cells. IDO1 overexpression has been observed in a wide range of human cancers such as prostatic, colorectal, pancreatic, cervical, gastric, ovarian, head or lung cancer. Physiological IDO1 activity has been implicated in T cell tolerance to tumors, dysfunctional selftolerance in non-obese diabetic (NOD) mice, and as a protective negative regulator in autoimmune disorders.

    UniProt

    P14902

    Pathways

    Activated T Cell Proliferation
Sie sind hier:
Chat with us!